Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States.

Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, Burgess R, Berges BK, Quaye A, Poole BD. · 2020

Read Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. by Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, Burgess R, Berges BK, Quaye A, Poole BD. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7711655.txt.

Introduction

Pogue and co-authors survey US attitudes toward a then-future COVID-19 vaccine. A vaccine could control the pandemic only if most people took it. The team surveyed 316 respondents across the United States. They modeled which beliefs and habits predicted support for vaccination.

About 68% of respondents backed getting vaccinated. Past vaccine use and past vaccine attitudes were the strongest predictors. How grave people judged COVID-19 for the nation also mattered. Side effects, weak effect, and short testing were the main worries. Longer testing, higher efficacy, and US development each raised support. The authors advise messages that calm fears in the already hesitant.

Catalog record

CREATORPogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, Burgess R, Berges BK, Quaye A, Poole BD.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7711655

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States By Kendall Pogue, Jamie L. Jensen, Carter K. Stancil, Daniel G. Ferguson, Savannah J. Hughes, Emily J. Mello, Ryan Burgess, Bradford K. Berges, Abraham Quaye, Brian D. Poole Published in: Vaccines DOI: 10.3390/vaccines8040582 ABSTRACT The COVID-19 pandemic continues to ravage the world, with the United States being highly affected. A vaccine provides the best hope for a permanent solution to controlling the pandemic. However, to be effective, a vaccine must be accepted and used by a large majority of the population. The aim of this study was to understand the attitudes towards and obstacles facing vaccination with a potential COVID-19 vaccine. To measure these attitudes a survey was administered to 316 respondents across the United States by a survey corporation. Structural equation modeling was used to analyze the relationships of several factors with attitudes toward potential COVID-19 vaccination. Prior vaccine usage and attitudes predicted attitudes towards COVID-19 vaccination. Assessment of the severity of COVID-19 for the United States was also predictive. Approximately 68% of all respondents were supportive of being vaccinated for COVID-19, but side effects, efficacy and length of testing remained concerns. Longer testing, increased efficacy and development in the United States were significantly associated with increased vaccine acceptance. Messages promoting COVID-19 vaccination should seek to alleviate the concerns of those who are already vaccine-hesitant. Messaging directed at the benefits of vaccination for the United States as a country would address the second predictive factor. Enough time should be taken to allay concerns about both short- and long-term side effects before a vaccine is released. 1. INTRODUCTION The COVID-19 pandemic has inflicted almost unimaginable harm on the life, health and economy of many nations. Along with hygienic and behavioral control measures, vaccination is the most successful way of limiting or eliminating viral infection and spread. Although the exact timing of when a vaccine against COVID-19 will be available is unknown, several candidates are being pursued, and it is likely that at least one effective vaccine will soon become available [1]. States in the United States are being told by the Centers for Disease Control and Prevention to prepare for a vaccine by November 1 [2], which would likely not allow adequate time for FDA approval. Even the best vaccine cannot be effective if it is not used. Recent surveys found that only 49% and 70% of residents of the United States of America plan to receive a COVID-19 vaccine when available [3,4]. This number of participants is likely below the threshold needed for homogeneous herd immunity [5], and will leave many residents vulnerable to the disease, even with a vaccine available. The problem of vaccine refusal has many contributing factors and is present worldwide [6,7]. The World Health Organization (WHO) recommends a preemptive strategy to overcome vaccine hesitancy and build trust in a vaccine to prepare for maximum efficacy when a vaccine is available [8,9]. Controlling or ending the pandemic through a vaccination program requires an understanding of the reasons behind hesitancy towards a COVID-19 vaccine in the United States, as well as strategies to overcome this hesitancy. Understanding varying vaccine attitudes is especially important since a heterogeneous approach to vaccine refusal that deals with the concerns of different groups is more effective than a homogenous strategy [10,11,12]. A qualitative and quantitative understanding of attitudes towards vaccine development and confidence is especially urgent in the United States, given recent messages that COVID-19 vaccine development is being accelerated and a vaccine may be released even before clinical trials are completed. Several strategies exist for ameliorating vaccine hesitancy. Our previous work explored strategies for improving opinions about vaccines among vaccine-hesitant college students. We found that focusing on the physical, social and emotional impacts of the diseases, either by having students interview someone who had suffered from a vaccine-preventable disease, or by taking a course with a heavy focus on the diseases that can be prevented by vaccination, significantly improved attitudes towards vaccines in the vaccine-hesitant students [13]. A study of elderly adults in the United States found that access to health information was a positive predictor for receiving vaccines [14]. In a very large study of United States adults, hesitancy towards the influenza vaccine was found to be much higher than hesitancy towards vaccines in general, an attitude resulting primarily from concerns about efficacy [15]. The low level of confidence in a COVID-19 vaccine is likely a result of multiple factors found to influence confidence regarding other vaccines, such as confidence in efficacy of the vaccine, fear of side effects [16], and trust in the government and those developing and administering the vaccines [17]. Lower economic status and lower education have also been associated with vaccine refusal [18]. Since people are currently experiencing the COVID-19 pandemic in real-time, there is unfortunately an opportunity to investigate the role of personal experience with disease, demographic factors, social conscience and the development, timing and nature of the vaccine itself in vaccine hesitancy. We designed a survey using structural equation modeling to investigate multiple potential contributing factors to COVID-19 vaccine refusal. The survey was distributed throughout the United States. We hypothesized that personal experience with COVID-19, whether being diagnosed personally or knowing someone who was diagnosed, would be important in determining the participants’ attitudes towards the vaccine. Considerations such as the closeness of the relationship to a diagnosed person and the severity of their disease were considered as part of this hypothesis. We also hypothesized that an individual’s knowledge about the SARS-CoV-2 coronavirus and COVID-19 disease would also be a determining factor towards COVID-19 vaccine attitudes. Furthermore, we expected that an individual’s attitudes towards vaccines in general would be an important factor in their willingness to receive a COVID-19 vaccine when one becomes available. Overall vaccine hesitancy is likely to play a large role in COVID-19 vaccine hesitancy, especially since vaccine hesitancy has been growing in more than 90% of countries [19] and has now been identified by the WHO as one of the greatest threats to global health. The model also included demographic factors and attitudes towards the severity of the COVID-19 pandemic. Along with the modeled predictors of vaccine attitude, we examined how the timing of the vaccine development process, the effectiveness of the final vaccine, and the location where the vaccine is developed would affect attitudes towards a COVID-19 vaccine. 2. MATERIALS AND METHODS 2.1. Measures We constructed and administered a survey to measure multiple factors related to the impact of COVID-19, the opinions and knowledge of participants about the disease and about vaccines and the intention and behavior of participants regarding a potential COVID-19 vaccine and vaccines in general, as well as demographic factors such as age, race, sex, and indicators of income. Additional items were included to evaluate factors such as the length of testing respondents perceived to be effective, how efficacy affects the likelihood to vaccinate, and how the location of vaccine development affects comfort with the vaccine. The survey was administered by Qualtrics (Provo, UT, USA) across the United States. In total 316 responses were collected according to census demographics (see demographics section for further details). The survey was administered via email notification through the Qualtrics survey

Read the complete text